IMMUNETHEP's Grant

IMMUNETHEP raised a round of funding on October 25, 2017. Investors include Bill & Melinda Gates Foundation.

IMMUNETHEP is a biotechnology company that is a Spin-off from the University of Oporto focused on drug development for Immune System related pathologies.…

Articles about IMMUNETHEP's Grant: